SIGA — SIGA Technologies Inc
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
$3.23
-$0.01 (-0.31%)
SIGA Technologies Inc (SIGA) is a drug manufacturers - specialty & generic company listed on NASDAQ. It is led by Diem Nguyen M.B.A., Ph.D., based in 31 East 62nd Street, New York, NY, United States, 10065, with about 49 employees. SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
Latest reported SIGA revenue for 2025-09-30 was $2.6M. Net income was -$6.4M. Revenue was down 96.8% from 2025-06-30 to 2025-09-30. SIGA currently screens at market cap $308.4M and trailing P/E 15.4.
Use this SIGA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SIGA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SIGA SEC filings page. Lician reads the product cache first so this HTML stays unique to SIGA Technologies Inc even when a live quote feed is slow.
About SIGA Technologies Inc
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
SIGA Key Statistics
Market Cap
$308.41M
Volume
651,120
Previous Close
$3.04
Day Range
$3.00 – $3.11
P/E Ratio
15.36
EPS
$0.82
Revenue
$138.72M
Net Income
$59.21M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
-0.9%
Profit Margin
42.7%
Employees
49
SIGA Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $138.72M | $139.92M | $110.78M | $133.67M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $59.21M | $68.07M | $33.90M | $69.45M |
| EPS (Diluted) | $0.82 | $0.95 | $0.46 | $0.91 |
Total Assets
$244.34M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$155.40M
Operating Cash Flow
$48.76M
Free Cash Flow
$0.00
SIGA Technologies Inc Company Information
- CEO & Director
- Diem Nguyen M.B.A., Ph.D.
- Headquarters
- 31 East 62nd Street, New York, NY, United States, 10065
- Website
- www.siga.com
- Phone
- 212 672 9100
- IPO / Founded
- 1997-09-09
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic